<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04873739</url>
  </required_header>
  <id_info>
    <org_study_id>Anterior segment OCT in SLE</org_study_id>
    <nct_id>NCT04873739</nct_id>
  </id_info>
  <brief_title>AS-OCT Study of Cornea and Tear Film Parameters in SLE Patients</brief_title>
  <official_title>Anterior Segment Optical Coherence Tomography Study of Cornea and Tear Film Parameters in Systemic Lupus Erythematous Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minia University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of thie study to assess tear film parameters such as tear meniscus height (TMH), tear&#xD;
      meniscus area (TMA), and tear meniscus depth (TMD). In addition, corneal pachymetry and&#xD;
      epithelial thickness maps in SLE patients and compared to healthy subjects of similar age and&#xD;
      gender.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Systemic lupus erythematous (SLE) is a relapsing and remitting autoimmune connective tissue&#xD;
      disorder that can affect many organs such as skin, joints, kidneys, eye, and brain (1) . SLE&#xD;
      has a global prevalence of 0.3 to 23.2 cases per 100,000. Women are more likely than men to&#xD;
      develop the disease. Four out of the following 11 diagnostic criteria are sufficient for the&#xD;
      diagnosis of SLE, malar rash, discoid rash, oral ulcers, non-erosive arthritis, serositis,&#xD;
      photosensitivity, renal disorder, neurological disorder, hematological disorder,&#xD;
      immunological disorder, and presence of antinuclear antibodies. (2,3)&#xD;
&#xD;
      Ocular manifestations occur in about one third of SLE patients with keratoconjunctivitis&#xD;
      sicca being the most common manifestation which is characterized by decreased tear film&#xD;
      aqueous layer. Scleritis, retinal vasculitis (which is often associated with CNS lupus), and&#xD;
      papillitis are considered as the most serious ocular manifestations. (4)&#xD;
&#xD;
      Corneal involvement in SLE affects the superficial epithelium, resulting in superficial&#xD;
      punctate keratitis, which is believed to be caused by Sjögren&amp;#39;s syndrome (SS). However,&#xD;
      some cases of non-infiltrative and infiltrative peripheral ulcerative keratitis have been&#xD;
      identified (5) .&#xD;
&#xD;
      Schirmer&amp;#39;s test and fluorescein breakup time test (FBUT) are two common clinical tests&#xD;
      used to analyze tear film. (6,7) Using an in vivo, non- contact technique, anterior segment&#xD;
      optical coherence tomography (AS- OCT) is now used to image the tear film, measure the lower&#xD;
      tear film height and area, measure corneal thickness (pachymetry), and measure surface&#xD;
      epithelial thickness. (8,9)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Actual">March 30, 2021</completion_date>
  <primary_completion_date type="Actual">February 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of Tear meniscus</measure>
    <time_frame>3 months</time_frame>
    <description>to measure lower tear meniscus height and area and depth with AS-OCT and comparing results between 3 groups; SLE patients with dry eye, SLE patients without dry eye and normal subjects.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of corneal structural changes</measure>
    <time_frame>3 months</time_frame>
    <description>To measure corneal Thickness, epithelial thickness and stromal thickness using AS-OCT comparing results between 3 groups; SLE patients with dry eye, SLE patients without dry eye and normal subjects.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Systemic Lupus Erythematosus</condition>
  <arm_group>
    <arm_group_label>20 patients SLE with dry eye</arm_group_label>
    <description>Anterior segment OCT for SLE patients with dry eye</description>
  </arm_group>
  <arm_group>
    <arm_group_label>30 patients SLE without dry eye</arm_group_label>
    <description>Anterior segment OCT for SLE patients without dry eye</description>
  </arm_group>
  <arm_group>
    <arm_group_label>50 normal subjects as control group of similar age and gender</arm_group_label>
    <description>Anterior segment OCT for normal subjects</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Anterior Segment OCT</intervention_name>
    <description>AS-OCT for SLE patients with dry eye, SLE patients without dry eye and compare them with normal subjects.</description>
    <arm_group_label>20 patients SLE with dry eye</arm_group_label>
    <arm_group_label>30 patients SLE without dry eye</arm_group_label>
    <arm_group_label>50 normal subjects as control group of similar age and gender</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Residents of Minia Governorate diagnosed with SLE and healthy one&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age ≥18 years old..&#xD;
&#xD;
          2. Patients with SLE diagnosed by a rheumatologist with no ocular involvement upon&#xD;
             clinical examination&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  1. Patients with history of intraocular surgery as cataract surgery ,retinal&#xD;
             detachment surgery, anti-glucoma surgery.&#xD;
&#xD;
             2. Patients with history of any corneal refractive surgery as LASIK, PRK. 3. Patients&#xD;
             with significant media opacity as corneal opacity, cataract. 4. Patients with ocular&#xD;
             diseases as glaucoma, uveitis. 5. Patients with any retinal affection as pathological&#xD;
             myopia, macular hole, age related macular degeneration and retinal vascular occlusion.&#xD;
&#xD;
             6. Patients with systemic diseases as diabetes mellitus, hypertension, abnormal kidney&#xD;
             function.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed Abdelkader, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Minia University hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed Salah, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Minia University hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed Hamid, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Minia University hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Minia university hospital</name>
      <address>
        <city>Minya</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Palejwala NV, Walia HS, Yeh S. Ocular manifestations of systemic lupus erythematosus: a review of the literature. Autoimmune Dis. 2012;2012:290898. doi: 10.1155/2012/290898. Epub 2012 Jul 2.</citation>
    <PMID>22811887</PMID>
  </reference>
  <reference>
    <citation>Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology (Oxford). 2017 Nov 1;56(11):1945-1961. doi: 10.1093/rheumatology/kex260. Review.</citation>
    <PMID>28968809</PMID>
  </reference>
  <reference>
    <citation>Yu C, Gershwin ME, Chang C. Diagnostic criteria for systemic lupus erythematosus: a critical review. J Autoimmun. 2014 Feb-Mar;48-49:10-3. doi: 10.1016/j.jaut.2014.01.004. Epub 2014 Jan 21. Review.</citation>
    <PMID>24461385</PMID>
  </reference>
  <reference>
    <citation>Read RW. Clinical mini-review: systemic lupus erythematosus and the eye. Ocul Immunol Inflamm. 2004 Jun;12(2):87-99. Review.</citation>
    <PMID>15512979</PMID>
  </reference>
  <reference>
    <citation>Benítez del Castillo JM, Wasfy MA, Fernandez C, Garcia-Sanchez J. An in vivo confocal masked study on corneal epithelium and subbasal nerves in patients with dry eye. Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3030-5.</citation>
    <PMID>15326117</PMID>
  </reference>
  <reference>
    <citation>Kanellopoulos AJ, Aslanides IM, Asimellis G. Correlation between epithelial thickness in normal corneas, untreated ectatic corneas, and ectatic corneas previously treated with CXL; is overall epithelial thickness a very early ectasia prognostic factor? Clin Ophthalmol. 2012;6:789-800. doi: 10.2147/OPTH.S31524. Epub 2012 May 23.</citation>
    <PMID>22701079</PMID>
  </reference>
  <reference>
    <citation>Nguyen P, Huang D, Li Y, Sadda SR, Ramos S, Pappuru RR, Yiu SC. Correlation between optical coherence tomography-derived assessments of lower tear meniscus parameters and clinical features of dry eye disease. Cornea. 2012 Jun;31(6):680-5. doi: 10.1097/ICO.0b013e3182261577.</citation>
    <PMID>22378111</PMID>
  </reference>
  <reference>
    <citation>Li Y, Tan O, Brass R, Weiss JL, Huang D. Corneal epithelial thickness mapping by Fourier-domain optical coherence tomography in normal and keratoconic eyes. Ophthalmology. 2012 Dec;119(12):2425-33. doi: 10.1016/j.ophtha.2012.06.023. Epub 2012 Aug 20.</citation>
    <PMID>22917888</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>April 30, 2021</study_first_submitted>
  <study_first_submitted_qc>April 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2021</study_first_posted>
  <last_update_submitted>June 5, 2021</last_update_submitted>
  <last_update_submitted_qc>June 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minia University</investigator_affiliation>
    <investigator_full_name>Mohamed Farouk Sayed Othman Abelkader</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>anterior segment optical coherence tomography</keyword>
  <keyword>tear film</keyword>
  <keyword>dry eye</keyword>
  <keyword>systemic lupus erythematous</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

